NCT03075046

Brief Summary

Vulvovaginal candidiasis (CVV) is an infectious process of the female genitourinary tract, an important health issue due to the high incidence and difficulties encountered in the treatment. Therefore, new therapeutic modalities are sought with the capacity to minimize drug side-effects and to reduce recurrent cases. The objective of this stufy is to evaluate the clinical and microbiological response of the 405 nm blue light emitting diode in the treatment of women with vulvovaginal candidiasis and in women with healthy gentourine treatment. A clinical trial was conducted involving 40 women, divided into two groups, the first group consisting of women with a confirmed CVV diagnosis and a second group formed by women with a healthy genitourinary tract, without symptoms and symptoms of the disease. Both groups underwent clinical evaluation and examination with endocervice collection with gynecologist before and after a session of application of the Blue Light Emitting Diode of 405 nm, lasting 4.5 minutes. There will also be an evaluation of the effects of the diary through the questionnaire answered before and after the participants' treatment. It is expected that the 405 nm blue LED will destroy the CVV fungus demonstrated by laboratory examination and also improve the signs and results analyzed by the gynecologist and participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 9, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

April 20, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2018

Completed
5.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

10 months

First QC Date

February 22, 2017

Last Update Submit

June 21, 2023

Conditions

Keywords

Blue Light Emitting DiodeWomen

Outcome Measures

Primary Outcomes (4)

  • Description of types of cells done by oncology and microflora cytology in women treated by blue light emitting diode

    These exam will be done by the collect of vaginal secretion to analyse types of cells and organisms

    15 days

  • Amount of clue cells quantified by fresh citology in vaginal secretion of women treated by blue light emitting diode

    These exam will be done by the collect of vaginal secretion using KOH 10% to analyse clue cells by percentage %

    5 hours

  • Value of vaginal pH measurement in women treated by blue light emitting diode

    These exam will be done by the collect of vaginal secretion using a ph measuring tape to analyse the hydrogen potential in -log10 \[aH+\] in women treated by blue light emitting diode. It will be used the numeric scale of pH value

    30 minutes

  • Quantification of fungal colony units by the fungus culture in vaginal secretion of women treated by blue light emitting diode

    These exam will be done by the collect of vaginal secretion using Colony Forming Unit CFU in women treated by blue light emitting diode

    15 days

Study Arms (3)

blue LED 405 nm in vulvovaginal candidiasis

EXPERIMENTAL

It will be applied the a 405 nm blue LED in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session. This part of the study will see if there is fungicidal effect of the blue led 405 nm

Device: Blue LED 405 nmOther: Questionnaire of anamnesis

blue LED 405 nm in healthy women

EXPERIMENTAL

It will be applied the a 405 nm blue LED in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session.This part of the study will see the security and the effects of the blue led 405 nm in healthy vaginal microflora

Device: Blue LED 405 nmOther: Questionnaire of anamnesis

Sociodemographic data of women with vulvovaginal candidiasis

NO INTERVENTION

The women will answer some questions of the anamnesis as: Age, weight, height, form of intimate hygiene, and others to evaluate possible correlations of these data with the presence of vulvovaginal candidiasis

Interventions

It will be applied a 405 nm blue Tonderm LED with a power of 1.66 W / m2, in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session.

blue LED 405 nm in healthy womenblue LED 405 nm in vulvovaginal candidiasis

The participants will answer the anamnesis Questionnaire that will be applied by the physiotherapist

blue LED 405 nm in healthy womenblue LED 405 nm in vulvovaginal candidiasis

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women betwen 18 and 65 years old, with clinical suspect of vulvovaginal candidiasis and with health vaginal tract

You may not qualify if:

  • Women with pacemakers, with diagnosis and / or suspicion of neoplasias, cognitive deficits, neurological and / or psychiatric diseases, pregnant women and women who have used oral antibiotics, fungicides, corticosteroids and vaginal creams in the last 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Atenção ao Assoalho Pelvico

Salvador, Estado de Bahia, 40.290-000, Brazil

RECRUITING

Related Publications (2)

  • Pereira E Silva ACM, Brito MB, Robatto M, Pavie MC, Villas Boas AQ, Sousa R, Lordelo P. Blue Light-Emitting Diode Therapy for Chronic Vulvovaginitis Symptoms: A Series of Cases. Photobiomodul Photomed Laser Surg. 2022 Nov;40(11):747-750. doi: 10.1089/photob.2022.0038.

  • Pavie MC, Robatto M, Bastos M, Tozetto S, Boas AV, Vitale SG, Lordelo P. Blue light-emitting diode in healthy vaginal mucosa-a new therapeutic possibility. Lasers Med Sci. 2019 Jul;34(5):921-927. doi: 10.1007/s10103-018-2678-3. Epub 2018 Nov 7.

MeSH Terms

Conditions

Candidiasis, Vulvovaginal

Condition Hierarchy (Ancestors)

CandidiasisMycosesBacterial Infections and MycosesInfectionsVulvovaginitisVaginitisVaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVulvitisVulvar DiseasesGenital Diseases

Central Study Contacts

Patrícia Lordêlo, post doc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2017

First Posted

March 9, 2017

Study Start

April 20, 2017

Primary Completion

February 20, 2018

Study Completion

December 1, 2023

Last Updated

June 22, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Informed Consent Form Access

Locations